Literature DB >> 5664149

The mechanism of the augmentation of responses to indirectly acting sympathomimetic amines by monoamine oxidase inhibitors.

M J Rand, F R Trinker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5664149      PMCID: PMC1570221          DOI: 10.1111/j.1476-5381.1968.tb00990.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


× No keyword cloud information.
  59 in total

1.  MONOAMINE-OXIDASE INHIBITORS, BROAD BEANS, AND HYPERTENSION.

Authors:  J V HODGE; E R NYE; G W EMERSON
Journal:  Lancet       Date:  1964-05-16       Impact factor: 79.321

2.  THE EXCRETION OF DEXAMPHETAMINE AND ITS DERIVATIVES.

Authors:  A M ASATOOR; B R GALMAN; J R JOHNSON; M D MILNE
Journal:  Br J Pharmacol Chemother       Date:  1965-02

3.  [Experimental animal research on the mechanism of the narcosis-shortening action of monoamine oxidase inhibitors].

Authors:  E WESTERMANN; K STOCK
Journal:  Chemotherapia (Basel)       Date:  1962

4.  Effect of inhibitors of monoamine oxidase on various enzymes and on the storage of monoamines.

Authors:  K F GEY; A PLETSCHER; W BURKARD
Journal:  Ann N Y Acad Sci       Date:  1963-07-08       Impact factor: 5.691

5.  Effect of iproniazid on monoamines and monamine oxidase in human brain.

Authors:  P O GANROT; E ROSENGREN; C G GOTTFRIES
Journal:  Experientia       Date:  1962-06-15

6.  Species differences in the cardiac effects of a monoamine oxidase inhibitor.

Authors:  N D GOLDBERG; F E SHIDEMAN
Journal:  J Pharmacol Exp Ther       Date:  1962-05       Impact factor: 4.030

7.  Norepinephrine metabolism in rat brain and heart.

Authors:  J R CROUT; C R CREVELING; S UDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1961-06       Impact factor: 4.030

8.  Metabolism of epinephrine and other sympathomimetic amines.

Authors:  J AXELROD
Journal:  Physiol Rev       Date:  1959-10       Impact factor: 37.312

9.  Studies on sympathomimetic amines. II. The biotransformation and physiological disposition of d-amphetamine, d-p-hydroxyamphetamine and d-methamphetamine.

Authors:  J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1954-03       Impact factor: 4.030

10.  Experimental observations on the effects of adrenaline after treatment with antidepressant monoamine oxidase inhibitor (MAOI) drugs.

Authors:  F R Trinker; H Fearn; M W McCulloch; M J Rand
Journal:  Aust Dent J       Date:  1967-08       Impact factor: 2.291

View more
  6 in total

1.  Cough and cold remedies: a potential danger to patients on monoamine oxidase inhibitors.

Authors:  M F Cuthbert; M P Greenberg; S W Morley
Journal:  Br Med J       Date:  1969-02-15

2.  Interactions between sympathomimetic amines and antidepressant agents in man.

Authors:  A J Boakes; D R Laurence; P C Teoh; F S Barar; L T Benedikter; B N Prichard
Journal:  Br Med J       Date:  1973-02-10

3.  Idiopathic postural hypotension: physiologic observations and report of a new mode of therapy.

Authors:  M A Diamond; R H Murray; P G Schmid
Journal:  J Clin Invest       Date:  1970-07       Impact factor: 14.808

4.  Modification of the vasoconstrictor action of sympathomimetic agents by bretylium tosylate and tranylcypromine in man.

Authors:  D B Frewin; L B Jellett; R F Whelan
Journal:  Br J Pharmacol       Date:  1969-07       Impact factor: 8.739

5.  An inhibitory role for brain serotonin-containing systems in the locomotor effects of d-amphetamine.

Authors:  A S Hollister; G R Breese; C M Kuhn; B R Cooper; S M Schanberg
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

6.  Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.

Authors:  P Bitsios; R W Langley; S Tavernor; K Pyykkö; M Scheinin; E Szabadi; C M Bradshaw
Journal:  Br J Clin Pharmacol       Date:  1998-06       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.